Literature DB >> 2785516

Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients.

C R Hume1, L A Shookster, N Collins, R O'Reilly, J S Lee.   

Abstract

Types II and III bare lymphocyte syndrome (BLS) are severe or lethal congenital immunodeficiencies characterized by defective cell surface expression of HLA class II antigens. We have analyzed by Southern and Northern blotting B-lymphoblastoid cell lines derived by Epstein-Barr virus (EBV) transformation from peripheral blood lymphocytes of two unrelated BLS patients and their families. While DNA analyses of both families showed no indication of rearrangement or alteration of HLA region genes, class II mRNAs were virtually absent in the patients' cell lines (BLS-1 and BLS-2). This is consistent with previous observations of different BLS patients and their families. An exception to the absence of class II mRNAs in BLS was the detection of low quantities of HLA-DQ alpha transcripts in the cell lines BLS-1. This finding provides further evidence that factors regulating HLA-DQ expression may differ from those governing expression of the other class II genes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785516     DOI: 10.1016/0198-8859(89)90065-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  22 in total

1.  A cDNA clone for a novel nuclear protein with DNA binding activity.

Authors:  T Mattioni; C R Hume; S Konigorski; P Hayes; Z Osterweil; J S Lee
Journal:  Chromosoma       Date:  1992-10       Impact factor: 4.316

2.  Transcription analysis of class II human leukocyte antigen genes from normal and immunodeficient B lymphocytes, using polymerase chain reaction.

Authors:  M Bull; A van Hoef; J Gorski
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

3.  New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.

Authors:  Michal Krawczyk; Krzysztof Masternak; Madeleine Zufferey; Emmanuèle Barras; Walter Reith
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

Review 4.  Genetics of HLA class II regulation.

Authors:  C R Hume; J S Lee
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

5.  Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.

Authors:  B S Nepom; G T Nepom; M Coleman; W W Kwok
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

6.  Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.

Authors:  T Scholl; S K Mahanta; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

7.  Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome.

Authors:  S Kovats; G T Nepom; M Coleman; B Nepom; W W Kwok; J S Blum
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Definition of a novel complementation group in MHC class II deficiency.

Authors:  A Peijnenburg; B Godthelp; A van Boxel-Dezaire; P J van den Elsen
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

9.  Reversion of a transcriptionally defective MHC class II-negative human B-cell mutant.

Authors:  M N Ombra; C Perfetto; M Autiero; A M Anzisi; R Pasquinelli; A Maffei; G Del Pozzo; J Guardiola
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

Review 10.  Current concepts in DRA gene regulation.

Authors:  J P Ting
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.